These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology. Drake LA; Dinehart SM; Farmer ER; Goltz RW; Graham GF; Hordinsky MK; Lewis CW; Pariser DM; Skouge JW; Webster SB; Whitaker DC; Butler B; Lowery BJ; Sontheimer RD; Callen JP; Camisa C; Provost TT; Tuffanelli DL J Am Acad Dermatol; 1996 Oct; 35(4):609-14. PubMed ID: 8859292 [No Abstract] [Full Text] [Related]
3. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa]. Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075 [No Abstract] [Full Text] [Related]
4. [Therapeutic effectiveness of carbon dioxide-hydrosulfide baths of Piatigorsk in complex therapy for children with scleroderma]. Braĭtsev AV; Studnitsin AA; Nikitina MN; Kessel' VP; Marzeva GI Pediatriia; 1971 Nov; 50(11):30-2. PubMed ID: 4259038 [No Abstract] [Full Text] [Related]
5. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
6. [Scleroderma: an update on the pathogenesis and treatment]. Garza-Rodríguez V; Villarreal-Alarcón MA; Ocampo-Candiani J Rev Med Inst Mex Seguro Soc; 2013; 51(1):50-7. PubMed ID: 23550408 [TBL] [Abstract][Full Text] [Related]
7. [Pathohistological and histochemical changes in the skin of patients with scleroderma during treatment at the Sochi spa]. Al'ter SM Vestn Dermatol Venerol; 1971 Oct; 45(10):40-3. PubMed ID: 5134077 [No Abstract] [Full Text] [Related]
8. [Clinical, humoral and histological examination of the action of ACTH in generalized scleroderma]. MANCINI RE; STRINGA SG; CANEPA L Rev Argent Endocrinol Metab; 1957; Suppl 1():1-56. PubMed ID: 13579353 [No Abstract] [Full Text] [Related]
9. Recent developments in the therapy of localized and systemic sclerosis. Ferri C; Amer M; Bombardieri S Clin Dermatol; 1994; 12(2):323-32. PubMed ID: 8076272 [No Abstract] [Full Text] [Related]
10. General and local scleroderma in children and dermatomyositis and associated syndromes. Laxer RM; Feldman BM Curr Opin Rheumatol; 1997 Sep; 9(5):458-64. PubMed ID: 9309202 [TBL] [Abstract][Full Text] [Related]
11. [Conservative treatment of chronic lymphedema and sclerotic skin processes]. Konopik J Z Arztl Fortbild (Jena); 1984; 78(8):307-10. PubMed ID: 6233797 [No Abstract] [Full Text] [Related]
12. Prognosis and management of scleroderma and scleroderma-like disorders in children. Black CM Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633 [TBL] [Abstract][Full Text] [Related]
13. [Late results of treatment of children with scleroderma at the Sochi health resort]. Dovzhanskiĭ SI; Al'ter SM Vestn Dermatol Venerol; 1970 Nov; 44(11):69-71. PubMed ID: 4252340 [No Abstract] [Full Text] [Related]
14. [Systemic sclerosis--clinical course and treatment possibilities]. Szymańska E; Maj M; Rudnicka L Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791 [TBL] [Abstract][Full Text] [Related]
15. [Modern therapy of scleroderma]. Karadaglić D Vojnosanit Pregl; 1995; 52(4):389-94. PubMed ID: 8629375 [No Abstract] [Full Text] [Related]